Literature DB >> 24860402

1-(4-Bromo-benz-yl)-2-(4-bromo-phen-yl)-1H-benzimidazole.

Hua-Jun Ma1, Zhi-Rong Qu1.   

Abstract

There are two mol-ecules in the asymmetric unit of the title compound, C20H14Br2N2. In the first, the dihedral angles between the mean plane of the benzimidazole group and those of the 4-bromo-benzyl and 4-chloro-phenyl groups are 50.72 (17) and 71.29 (16)°, respectively, while the corresponding angles in the second mol-ecule are 42.09 (16) and 89.05 (17)°. The 4-bromo-benzyl and 4-bromo-phenyl groups make an angle of 68.1 (2) and 85.1 (21)° with each other in the two mol-ecules. In the crystal, weak C-H⋯N and C-H⋯Br hydrogen bonds link the mol-ecules along the c-axis direction. Br⋯Br inter-actions [3.5733 (9)Å] are also observed.

Entities:  

Year:  2014        PMID: 24860402      PMCID: PMC4011315          DOI: 10.1107/S1600536814009076

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


  4 in total

Review 1.  The combinatorial synthesis of bicyclic privileged structures or privileged substructures.

Authors:  Douglas A Horton; Gregory T Bourne; Mark L Smythe
Journal:  Chem Rev       Date:  2003-03       Impact factor: 60.622

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 3.  Imidazole and benzimidazole derivatives as chemotherapeutic agents.

Authors:  Mariana Boiani; Mercedes González
Journal:  Mini Rev Med Chem       Date:  2005-04       Impact factor: 3.862

Review 4.  Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes.

Authors:  Santanu Bhattacharya; Padmaparna Chaudhuri
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.